WEISS AMIR (Chief Accounting Officer) sold 41.9% of their position (9.45K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market
Open‑market sale worth $355.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/25/2026ACC: 0001193125-26-365116
Officer· Chief Accounting Officer
Since Nov 2021
-9.45K
Net shares
Net seller
$355.3K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
2.50K acquired · 11.95K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−6.95K
Price / share
$37.61
Trade value
$261.22K
% of position
34.7%
8/21/2026
20.02K→13.07K
Ordinary Shares
Direct
Shares
+2.50K
Price / share
$19.61
Trade value
$49.02K
% of position
19.1%
8/21/2026
13.07K→15.57K
Ordinary Shares
Direct
Shares
−2.50K
Price / share
$37.63
Trade value
$94.08K
% of position
16.1%
8/21/2026
15.57K→13.07K
Total
Net shares
−6.95K
Net value
-$306.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/21/2026 | S · Sale | −6.95K | $37.61 | $261.22K | 34.7% | 20.02K | 13.07K |
| Ordinary Shares Direct | 8/21/2026 | M · Option Exercise | +2.50K | $19.61 | $49.02K | 19.1% | 13.07K | 15.57K |
| Ordinary Shares Direct | 8/21/2026 | S · Sale | −2.50K | $37.63 | $94.08K | 16.1% | 15.57K | 13.07K |
| Total | −6.95K | -$306.28K | ||||||
Derivative Transactions1
Stock Options (right to buy)
Direct
Converts to
Ordinary Shares
2.50K shares
Shares
−2.50K
Strike price
19.16
Held after
7.50K
Exercisable
—
8/21/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) Direct | Ordinary Shares2.50K shares | 8/21/2026 | M · Option Exercise | −2.50K | 19.16 | — | 7.50K |